Frequently Asked Questions

No. The procedures discussed here target the area around peripheral nerves in the head and neck; they are not procedures on brain tissue.

It cannot be regarded as a definitive cure. There is disagreement about the evidence and appropriate patient selection; benefit and risk are assessed on an individual basis.

No. While ASPS discusses surgery targeting peripheral trigger points in selected patients, the American Headache Society's Choosing Wisely recommendation states that these interventions should not be recommended outside of clinical studies. This disagreement, the uncertainties, and non-surgical options should all be discussed when making a decision.

Immediate or complete resolution cannot be guaranteed. Evaluating the results requires follow-up; your existing neurology follow-up and medication plan should not be discontinued without consulting your physician.

Rates reported in studies can vary depending on patient selection, technique and how success is defined. A single rate cannot predict your individual outcome; expected benefit, the possibility of no response, and the limitations of the evidence should all be discussed.

Surgery can carry risks such as scarring, infection, bleeding, sensory changes and persistent pain. Risks specific to the individual and the treatment area should be assessed before surgery.

No. It is specifically considered for chronic migraine. Suitability is not decided without first establishing the type of headache and prior treatments tried.

Bring your headache diary, a list of the medications you use, treatments already tried, and any previous reports. If you are travelling from outside the city, ask about appointment and possible follow-up requirements in advance through our contact channels.

A sudden, very severe headache, or new weakness, speech difficulty, altered consciousness, or symptoms such as fever with neck stiffness require urgent evaluation. In these situations, call emergency services or go to the emergency department.